IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sands Capital Alternatives, LLC

Q1 2022 Holdings

Filed 2022-05-13 | 18 holdings | $18.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acumen Pharmaceuticals, Inc(ABOS)COM00509G209$13.4M3,417,07572.5%
Candel Therapeutics, Inc(CADL)COM137404109$4.1M811,73722.4%
Absci Corp.(ABSI)COM00091E109$487.0K57,8042.6%
Uipath Inc(PATH)COM CL A90364P105$82.3K3,811,7790.4%
NU Holdings Ltd.(NU)COM CL AG6683N103$70.5K9,136,8350.4%
Doordash Inc(DASH)COM CL A25809K105$70.5K601,4540.4%
Dice Therapeutics, Inc.COM23345J104$60.2K3,148,9700.3%
Snowflake Inc(SNOW)COM CL A833445109$49.2K214,6210.3%
Samsara, Inc.COM CL BFDS1Q2O30$43.5K2,712,2560.2%
Karuna Therapeutics, Inc.COM48576A100$34.0K267,8950.2%
Cincor Pharma, Inc.COM17240Y109$16.7K950,0000.1%
Olink Holding ABCOM680710100$7.5K425,5140.0%
908 Devices Inc(MASS)COM65443P102$6.2K326,4270.0%
Samsara, Inc.(IOT)COM CL A79589L106$5.2K326,0000.0%
Taysha Gene Therapies Inc(TSHA)COM877619106$4.7K724,8730.0%
Tarsus Pharmaceuticals Inc(TARS)COM87650L103$4.4K260,0000.0%
Repligen Corp.(RGEN)COM759916109$4.2K22,5440.0%
Spruce Biosciences IncCOM85209E109$1.6K787,0070.0%